secwatch.observer — SEC 8-K summary
======================================

Issuer:     RIGEL PHARMACEUTICALS INC (RIGL)
CIK:        0001034842
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001104659-23-065988
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Rigel shareholders approve equity plan amendment adding 4M shares, elect directors
--------------------------------------------------------------------------------

- Stockholders approved amendment to 2018 Equity Incentive Plan, increasing authorized shares by 4,000,000.
- Three directors elected: Alison L. Hannah, Walter H. Moos, Raul R. Rodriguez.
- Advisory say-on-pay approved with 76.6 million votes for.
- Board determined to hold annual advisory vote on executive compensation.
- Ratification of Ernst & Young as independent auditor for fiscal 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1034842/000110465923065988/0001104659-23-065988-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1034842/000110465923065988/tm2317252d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-065988

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer